Free Trial

Mirum Pharmaceuticals (MIRM) SEC Filings & 10K Form

Mirum Pharmaceuticals logo
$41.51 +0.38 (+0.92%)
(As of 12/20/2024 05:16 PM ET)

Recent Mirum Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/15/2024
4:34 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:32 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:34 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:44 AM
BlackRock, Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
10/01/2024
3:39 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:39 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:18 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:04 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:11 PM
Mirum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
4:32 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
12:12 PM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G
07/03/2024
5:19 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:35 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
4:15 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:31 PM
Mirum Pharmaceuticals (Subject)
Vig Pamela (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
7:03 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
5:19 PM
Fairey William (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Mirum Pharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:21 PM
Fischer Laurent (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:22 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:22 PM
Brege Laura (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:23 PM
Cardon Lon (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:24 PM
Mirum Pharmaceuticals (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:25 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:38 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:24 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
3:30 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:16 PM
Mirum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2024
3:20 PM
Mirum Pharmaceuticals (Filer)
Form DEF 14A
04/23/2024
3:21 PM
Mirum Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
7:47 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:41 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:44 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:46 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:34 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:37 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:40 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:32 PM
Mirum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

03/15/2024
4:03 PM
Mirum Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
3:05 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
11:49 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2024
8:04 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:05 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:10 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:12 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
8:28 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
6:39 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/18/2024
6:42 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:21 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:25 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:28 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:09 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:12 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:30 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MIRM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners